Bio-Performance Micro-Click Concentrate is Shiseido’s new precision treatment inspired by in-office procedures.

Hong known for weaving scientific research with a distinctly Japanese approach to skincare, Shiseido has often focussed on treatments that work with the skin rather than overwhelm it. Its latest release, the Bio-Performance Micro-Click Concentrate, follows that same line of thinking but introduces a more technical edge, one inspired by the precision of aesthetic procedures.
This is not a product that you smooth on and forget about. It arrives with an applicator fitted with 18 ultra-fine micropoints, each measuring around 20 microns. When pressed onto the skin, these tiny points are designed to create microscopic pathways, allowing the accompanying serum to be delivered more effectively into the upper layers of the skin. The brand explains that the motion also provides a form of mechanical stimulation, encouraging the skin’s natural renewal responses in a controlled, non-invasive way. A small doughnut-shaped guard sits at the base of each tip to ensure that pressure and depth remain consistent and gentle.


Niacinamide, a form of vitamin B3, is central to the formulation. It is known within the skincare world for its ability to strengthen the skin barrier, refine texture and contribute to improved firmness over time. Shiseido pairs this with a Barrier Fill Complex, which is meant to support the skin after the active ingredients have been absorbed.
The treatment is designed to be used in two stages: first, an ‘intensive phase’ applied every two days over the course of 12 days, followed by a weekly ‘amplifying phase’ to maintain the effects. Shiseido’s own consumer studies claim that many participants reported improvements in the visibility of wrinkles, firmness and pore appearance. Though, as always, individual results vary. The Micro-Click Concentrate is better suited to those who appreciate skincare with structure and precision, a little something to bridge the gap between daily routines and more invasive in-clinic treatments.